The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Hims & Hers Health Inc (NYSE: HIMS) closed at $49.28 down -25.79% from its previous closing price of $66.41. In other words, the price has decreased by -$25.79 from its previous closing price. On the day, 88.37 million shares were traded.
Ratios:
For a deeper understanding of Hims & Hers Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.38 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 71.96. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 18 ’25 when Dudum Andrew sold 128,127 shares for $58.27 per share. The transaction valued at 7,466,121 led to the insider holds 97,687 shares of the business.
Dudum Andrew sold 47,534 shares of HIMS for $2,763,942 on Feb 18 ’25. The Chief Executive Officer now owns 427,796 shares after completing the transaction at $58.15 per share. On Feb 18 ’25, another insider, Boughton Soleil, who serves as the Chief Legal Officer of the company, sold 4,152 shares for $60.69 each. As a result, the insider received 251,985 and left with 157,345 shares of the company.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 113.99, and their Forward P/E ratio for the next fiscal year is 90.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.67 while its Price-to-Book (P/B) ratio in mrq is 24.39.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $9.22. The 50-Day Moving Average of the stock is 41.57%, while the 200-Day Moving Average is calculated to be 108.38%.
Shares Statistics:
A total of 209.44M shares are outstanding, with a floating share count of 178.25M. Insiders hold about 18.42% of the company’s shares, while institutions hold 74.94% stake in the company.
